Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
22.34
-0.10 (-0.45%)
At close: Feb 21, 2025, 4:00 PM
22.33
-0.01 (-0.04%)
After-hours: Feb 21, 2025, 5:02 PM EST
Genmab Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 21,526 | 16,474 | 14,505 | 8,417 | 10,111 | Upgrade
|
| Revenue Growth (YoY) | 30.67% | 13.57% | 72.33% | -16.75% | 88.43% | Upgrade
|
| Cost of Revenue | 985 | 226 | - | - | - | Upgrade
|
| Gross Profit | 20,541 | 16,248 | 14,505 | 8,417 | 10,111 | Upgrade
|
| Selling, General & Admin | 3,790 | 3,297 | 2,676 | 1,283 | 661 | Upgrade
|
| Research & Development | 9,672 | 7,630 | 5,562 | 4,181 | 3,137 | Upgrade
|
| Operating Expenses | 13,462 | 10,927 | 8,238 | 5,464 | 3,798 | Upgrade
|
| Operating Income | 7,079 | 5,321 | 6,267 | 2,953 | 6,313 | Upgrade
|
| Interest Expense | -120 | -70 | -39 | -13 | -10 | Upgrade
|
| Interest & Investment Income | 995 | 982 | 324 | 197 | 184 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,339 | -889 | 1,051 | 1,470 | -1,456 | Upgrade
|
| EBT Excluding Unusual Items | 9,293 | 5,344 | 7,603 | 4,607 | 5,031 | Upgrade
|
| Merger & Restructuring Charges | -300 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 247 | 293 | -658 | -689 | 873 | Upgrade
|
| Asset Writedown | -76 | - | - | - | - | Upgrade
|
| Pretax Income | 9,164 | 5,637 | 6,945 | 3,918 | 5,904 | Upgrade
|
| Income Tax Expense | 1,320 | 1,285 | 1,493 | 961 | 1,146 | Upgrade
|
| Net Income | 7,844 | 4,352 | 5,452 | 2,957 | 4,758 | Upgrade
|
| Net Income to Common | 7,844 | 4,352 | 5,452 | 2,957 | 4,758 | Upgrade
|
| Net Income Growth | 80.24% | -20.18% | 84.38% | -37.85% | 119.67% | Upgrade
|
| Shares Outstanding (Basic) | 64 | 65 | 65 | 65 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 65 | 66 | 66 | 66 | 66 | Upgrade
|
| Shares Change (YoY) | -1.94% | -0.14% | -0.05% | 0.24% | 3.53% | Upgrade
|
| EPS (Basic) | 122.21 | 66.64 | 83.38 | 45.22 | 73.00 | Upgrade
|
| EPS (Diluted) | 121.36 | 66.02 | 82.59 | 44.77 | 72.21 | Upgrade
|
| EPS Growth | 83.82% | -20.06% | 84.48% | -38.00% | 112.20% | Upgrade
|
| Free Cash Flow | 7,584 | 7,014 | 3,595 | 1,976 | 6,126 | Upgrade
|
| Free Cash Flow Per Share | 117.34 | 106.41 | 54.46 | 29.92 | 92.98 | Upgrade
|
| Gross Margin | 95.42% | 98.63% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | 32.89% | 32.30% | 43.21% | 35.08% | 62.44% | Upgrade
|
| Profit Margin | 36.44% | 26.42% | 37.59% | 35.13% | 47.06% | Upgrade
|
| Free Cash Flow Margin | 35.23% | 42.58% | 24.78% | 23.48% | 60.59% | Upgrade
|
| EBITDA | 7,390 | 5,529 | 6,555 | 3,147 | 6,543 | Upgrade
|
| EBITDA Margin | 34.33% | 33.56% | 45.19% | 37.39% | 64.71% | Upgrade
|
| D&A For EBITDA | 311 | 208 | 288 | 194 | 230 | Upgrade
|
| EBIT | 7,079 | 5,321 | 6,267 | 2,953 | 6,313 | Upgrade
|
| EBIT Margin | 32.89% | 32.30% | 43.21% | 35.08% | 62.44% | Upgrade
|
| Effective Tax Rate | 14.40% | 22.80% | 21.50% | 24.53% | 19.41% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.